These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18822715)
21. [Chemotherapy of head and neck cancer]. Kohno N; Nakazawa E; Kusunoki M; Nishiya M Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819 [TBL] [Abstract][Full Text] [Related]
22. Chemotherapy and combined modality therapy in head and neck cancer. Hamasaki VK; Vokes EE Curr Opin Oncol; 1993 May; 5(3):508-17. PubMed ID: 8494912 [TBL] [Abstract][Full Text] [Related]
23. The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer. Hill BT; Price LA Acta Oncol; 1990; 29(6):695-703. PubMed ID: 2223138 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapy in head and neck cancer. Armand JP; Couteau C Eur J Cancer; 1995; 31A(5):819-22. PubMed ID: 7640066 [No Abstract] [Full Text] [Related]
25. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas. Bernier J; Pfister DG; Cooper JS Crit Rev Oncol Hematol; 2005 Dec; 56(3):353-64. PubMed ID: 15979887 [TBL] [Abstract][Full Text] [Related]
26. Benefits of chemotherapy in head and neck cancer. Brockstein B Lancet; 2000 Aug; 356(9231):767-8. PubMed ID: 11085713 [No Abstract] [Full Text] [Related]
27. The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer. Garden AS J Clin Oncol; 2014 Sep; 32(25):2685-6. PubMed ID: 25049324 [No Abstract] [Full Text] [Related]
28. Commentary: bevacizumab and erlotinib with chemoradiation for head and neck cancer. Burtness B Cancer J; 2011; 17(5):273-5. PubMed ID: 21952274 [No Abstract] [Full Text] [Related]
29. Does DeCIDE give a decisive answer against induction chemotherapy in head and neck cancers? Chakraborty S; Patil VM J Clin Oncol; 2015 Mar; 33(8):967. PubMed ID: 25667296 [No Abstract] [Full Text] [Related]
30. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426 [TBL] [Abstract][Full Text] [Related]
31. Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Hartley A; Sanghera P; Glaholm J; Mehanna H; McConkey C; Fowler J Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):125-30. PubMed ID: 19880297 [TBL] [Abstract][Full Text] [Related]
32. RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas. Clin Adv Hematol Oncol; 2007 Feb; 5(2):79-81. PubMed ID: 17344795 [No Abstract] [Full Text] [Related]
33. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience. Katodritis N; Charalampous H; Vomvas D J BUON; 2012; 17(2):397. PubMed ID: 22740226 [No Abstract] [Full Text] [Related]
34. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer]. Shparyk IaV; Kravets AI; Bilyns'kyÄ BT; Kuftiak OF Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857 [No Abstract] [Full Text] [Related]
35. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053 [TBL] [Abstract][Full Text] [Related]
36. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region. Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480 [No Abstract] [Full Text] [Related]
37. Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Jacobs C; Pinto H Semin Oncol; 1995 Dec; 22(6):540-52. PubMed ID: 8539631 [No Abstract] [Full Text] [Related]
38. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532 [TBL] [Abstract][Full Text] [Related]
39. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425 [TBL] [Abstract][Full Text] [Related]
40. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]